---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-040518"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2021-08-05T23:59:59+00:00"
generated_at: "2026-06-29T21:33:47.020977+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q2 revenue up 358% YoY to $5.4M; net loss narrows to $0.3M

## Summary
- Revenue $5.4M, up 358% YoY and 77% sequentially; shipped 17 systems including 7 SRT-100 Vision.
- Net loss improved to $(0.3)M ($0.02 loss per share) from $(2.6)M loss in Q2 2020; Adjusted EBITDA $(0.1)M vs $(2.3)M.
- Cash $15.2M at June 30, 2021; worldwide installed base of SRT systems reached 515.
- CMS increased reimbursement for SRT effective Jan 2021; new leasing options; expanding international in China and India.
- Management cautiously optimistic for sequential growth; on track to profitability.

## SEC filing metadata
- accession: 0001213900-21-040518
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2021-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390021040518/0001213900-21-040518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390021040518/ea145134-8k_sensushealth.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-040518
- JSON: https://secwatch.observer/filing/0001213900-21-040518.json
- Plain text: https://secwatch.observer/filing/0001213900-21-040518.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.